Loading clinical trials...
Loading clinical trials...
The purpose of the study is to examine the effect of testosterone treatment on insulin in men with the metabolic syndrome with testosterone levels at or below the lower end of the normal range.
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Massachusetts General Hospital
Collaborators
NCT07547098 · Cardiovascular Diseases (CVD), Chronic Kidney Disease, and more
NCT06003686 · Spinal Cord Injuries, Obesity, and more
NCT06801769 · Pancreatic Steatosis, Metabolic Syndrome X, and more
NCT07237750 · Overweight and/or Obesity, Metabolic Syndrome, and more
NCT07460856 · Overweight/Obesity, Metabolic Syndrome, and more
Massachusetts General Hospital
Boston, Massachusetts
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions